Dr. Martinez presents research at Gottingen University-Max Planck Institutes in Germany, collaborations with Cancer Institute to follow

Dr. Martinez presents research at Gottingen University-Max Planck Institutes in Germany, collaborations with Cancer Institute to follow

WVU Cancer Institute’s Dr. Ivan Martinez and his lab will engage in collaborative research with their colleagues at The German Primate Center, part of the Gottingen University-Max Planck Institutes in Germany, later this year.

Dr. Martinez’s research on the role of RNAs in cancer development piqued the interest of Dr. Jens Gruber, professor at The Primate Center and his graduate student Nicolas Lemus, and they invited Martinez to their country recently to give a couple talks about his work at the Cancer Institute. They were especially interested in Martinez’s project related to the discovery of an alternative pathway of microRNA biogenesis. Part of this project was recently published in the Journal Proceedings of the National Academy of Sciences (PNAS, 2017).

MicroRNAs are small RNA molecules that are very important in the regulation of genes in normal and cancer cells. MicroRNA biogenesis is a process by which these molecules form, reshape and become active in cells. Martinez’s lab discovered a different microRNA biogenesis process in dormant cells, meaning cells that are in a “resting” or “quiescent” state. This discovery is important in the cancer field because understanding in detail this new process could help develop new treatments against dormant cancer stem cells, which are known to be more resistant to cancer therapy and responsible for cancer relapse.

“Nicolas Lemus found our publication on PubMed and realized that our data were the “missing link” that clarified his experimental findings,” Martinez said. “My German colleagues were very happy because our publication helped them put together a better story of their data.”

The collaboration between Gottingen University and the WVU Cancer Institute will begin with a three-month visit by Lemus to the Cancer Institute to learn how to develop specific techniques established in Martinez’s laboratory.

  • Gibson selected as an Executive Leadership in Academic Medicine Fellow

    Gibson selected as an Executive Leadership in Academic Medicine Fellow

    Lauren F. Gibson, Ph.D., senior associate vice president for research and graduate education at WVU Health Sciences, has been selected as a fellow in the Hedwig van Ameringen Executive Leadership in Academic Medicine Program for Women at Drexel University College of Medicine.

    Read More

  • Patrick Ma lab presents research at ASCO meeting, Xiaoliang Wu wins Merit Award

    Patrick Ma lab presents research at ASCO meeting, Xiaoliang Wu wins Merit Award

    Patrick Ma, M.D., co-leader of the WVU Cancer Institute Sara Crile Allen & James Frederick Allen Comprehensive Lung Cancer Program and director of the Clinical Lung Cancer Program, and Xiaoliang Wu, M.D., Ph.D., postdoctoral research fellow in Dr. Ma’s lab, were featured presenters at the 2018 American Society of Clinical Oncology (ASCO) Annual Scientific Meeting this June.

    Read More

  • NIH Funding Opportunities Available for High-Risk Research

    NIH Funding Opportunities Available for High-Risk Research

    The National Institutes of Health (NIH) Common Fund announces fiscal year 2019 funding opportunities for the NIH Director’s Pioneer Award, New Innovator Award, Transformative Research Award, and Early Independence Award in the High-Risk, High-Reward Research program.

    Read More